Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes
Status unconfirmed
Conditions studied: Cancer, Solid Tumor, Hematologic Malignancy
In brief
The primary research objective of this protocol is to evaluate the impact of integrating a home-based symptom monitoring system in the day-to-day care of cancer patients in community settings on the frequency of supportive symptom interventions, symptom severity, and quality of life.
Key facts
- Study ID
- NCT00300001
- Run by
- Community Cancer Care
- People needed
- 300
- Starts
- 2006-03-01
- Last updated by the study team
- 2006-08-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 18 years old or older Diagnosis of solid tumor or hematologic malignancy Starting active treatment (chemotherapy or hormonal therapy) Must be able to give informed consent \& consent to use the Cancer Symptom Monitor -
You may not qualify if…
- Inability to give informed consent Life expectancy of less than 3 months Subject has any kind of disorder that compromises the ability of the subject to give written informed consent and/or to comply with study procedures.
Where it is running
- Quality Oncology Care, Inc. — Indianapolis, Indiana, United States (enrolling)
- Community Regional Cancer Center-Community Hospital North — Indianapolis, Indiana, United States (enrolling)
- Morgan Hospital and Medical Center — Martinsville, Indiana, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.